Evidence map›Paper›PMID 42434685›Full record

ArticleHealth systems (Basingstoke, England)2026

Generative AI models for type 2 diabetes mellitus risk prediction.

Elsa Sharu Johnson, Uma Gandhi, U Srinivasulu Reddy, Umapathy Mangalanathan

Abstract read
In one paragraph

Article in Health systems (Basingstoke, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Elsa Sharu JohnsonThe Department of Instrumentation and Control Engineering, National Institute of Technology, Tiruchirappalli, India.
Uma GandhiThe Department of Instrumentation and Control Engineering, National Institute of Technology, Tiruchirappalli, India.
U Srinivasulu ReddyThe Department of Computer Applications, National Institute of Technology, Tiruchirappalli, India.
Umapathy MangalanathanThe Department of Instrumentation and Control Engineering, National Institute of Technology, Tiruchirappalli, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes, precisely Type II Diabetes Mellitus (T2DM), is a prevalent global chronic condition. This study focuses on improving the accuracy of predicting T2DM onset and risk by utilizing Generative Artificial Intelligence (GenAI) based synthetic data generation and innovative feature selection techniques. GenAI models such as Deep Tabular Augmentation (DTA) and Large Language Models (LLM) were utilized to address class imbalance and data scarcity of diabetes class for prediction. The Representative Instances-based Fuzzy Rough Set Feature Selection (FRS-RI) method was employed for optimal feature selection. Three diabetes datasets - Sylhet, Obesity, and Diagnostic Features - were employed. After FRS-RI feature selection and synthetic data generation, Machine Learning (ML), Ensemble Learning (EL), and Deep Learning (DL) models were trained on these datasets. The ML, EL, and DL models achieved impressive accuracy, precision, and recall scores: 95.19%, 0.96, and 0.94 for the Sylhet Dataset; 100%, 1.00, and 1.00 for the Obesity dataset; and 97.44%, 0.97, and 0.94 for the NIDDK-DF Dataset. The model's ability to generalize to new diabetic data was demonstrated by enhanced test accuracies of 98.37% and 97.33% obtained when the suggested techniques were applied to benchmark datasets such as PIMA and LMCH, respectively. Emphasis was also placed on model explainability to justify predictions for clinical presentation.

Indexed as

feature selectiongenerative AIlarge language modelsmachine learning and deep learningonset and risk predictionType II diabetes mellitus

Identifiers

PMID42434685
PMCPMC13353440

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.